This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is true concerning flow-dependent incentive spirometry devices? a. The ... (Read 47 times)

anjilletteb

  • Hero Member
  • *****
  • Posts: 569
Which of the following is true concerning flow-dependent incentive spirometry devices?
 
  a. The volume capacity for a child should be approximately 3 L.
  b. The patient must perform a sustained maximum inspiration.
  c. They are available as multiuse electrically powered devices.
  d. Positive pressure within the device causes the flexible plastic bellows to rise.

Question 2

A patient has undergone surgery and is receiving continuous supplemental oxygen via a 30 air-entrainment mask.
 
  He or she becomes pale and short of breath during incentive spirometry. Pulse oximetry reveals a significant drop in oxygen saturation during incentive spirometry. The respiratory therapist should do which of the following for subsequent incentive spirometry therapy?
  a. Switch to a different type of incentive spirometer.
  b. Request that incentive spirometry be dis-continued.
  c. Cut a hole in the mask for the incentive spirometer's mouthpiece.
  d. Use a 3 L/min nasal cannula during incen-tive spirometry.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wshriver

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

ANS: B
The performance of a sustained maximum inspiration is necessary to perform incentive spirometry with a flow-dependent incentive spirometer (or any incentive spirometry device).

Answer to Question 2

ANS: D
The drop in oxygen saturation during incentive spirometry is due to the interruption of oxygen therapy. For this patient it is necessary to maintain oxygen therapy during incentive spirometry. Because the use of a mask is difficult during incentive spirometry, a nasal cannula with a flow rate of 3 L/min will approximate the air-entrainment mask's 30 supplemental oxygen.





 

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

For a complete list of videos, visit our video library